6-136822665-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000288.4(PEX7):c.-1G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000437 in 1,373,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 35)
Exomes 𝑓: 0.0000044 ( 0 hom. )
Consequence
PEX7
NM_000288.4 5_prime_UTR
NM_000288.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.267
Genes affected
PEX7 (HGNC:8860): (peroxisomal biogenesis factor 7) This gene encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Defects in this gene cause peroxisome biogenesis disorders (PBDs), which are characterized by multiple defects in peroxisome function. There are at least 14 complementation groups for PBDs, with more than one phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene have been associated with PBD complementation group 11 (PBD-CG11) disorders, rhizomelic chondrodysplasia punctata type 1 (RCDP1), and Refsum disease (RD). [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX7 | NM_000288.4 | c.-1G>A | 5_prime_UTR_variant | 1/10 | ENST00000318471.5 | NP_000279.1 | ||
PEX7 | XM_006715502.3 | c.-1G>A | 5_prime_UTR_variant | 1/7 | XP_006715565.1 | |||
PEX7 | XM_047418874.1 | c.-1G>A | 5_prime_UTR_variant | 1/6 | XP_047274830.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX7 | ENST00000318471.5 | c.-1G>A | 5_prime_UTR_variant | 1/10 | 1 | NM_000288.4 | ENSP00000315680 | P1 | ||
PEX7 | ENST00000367756.8 | c.-1G>A | 5_prime_UTR_variant | 1/4 | 3 | ENSP00000356730 | ||||
PEX7 | ENST00000541292.6 | c.-1G>A | 5_prime_UTR_variant, NMD_transcript_variant | 1/11 | 5 | ENSP00000441004 | ||||
PEX7 | ENST00000678593.1 | upstream_gene_variant | ENSP00000503841 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD3 genomes
Cov.:
35
GnomAD3 exomes AF: 0.0000161 AC: 2AN: 124538Hom.: 0 AF XY: 0.0000293 AC XY: 2AN XY: 68354
GnomAD3 exomes
AF:
AC:
2
AN:
124538
Hom.:
AF XY:
AC XY:
2
AN XY:
68354
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000437 AC: 6AN: 1373834Hom.: 0 Cov.: 33 AF XY: 0.00000590 AC XY: 4AN XY: 678090
GnomAD4 exome
AF:
AC:
6
AN:
1373834
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
678090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 35
GnomAD4 genome
Cov.:
35
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 02, 2023 | Variant summary: PEX7 c.-1G>A is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 1.6e-05 in 124538 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-1G>A in individuals affected with Rhizomelic Chondrodysplasia Punctata Type 1 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at